Lataa...
New therapeutic strategies targeting D1-type dopamine receptors for neuropsychiatric disease
The neurotransmitter dopamine acts via two major classes of receptors, D1-type and D2-type. D1 receptors are highly expressed in the striatum and can also be found in the cerebral cortex. Here we review the role of D1 dopamine signaling in two major domains: L-DOPA-induced dyskinesias in Parkinson’s...
Tallennettuna:
| Julkaisussa: | Front Biol (Beijing) |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5340264/ https://ncbi.nlm.nih.gov/pubmed/28280503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11515-015-1360-4 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|